News Website

Dr Pillay: Endometrial cancer on the rise - The Fiji Times

Dr Pillay: Endometrial cancer on the rise The Fiji Times

Published: Oct. 16, 2025, 12:31 a.m.

Read Full Article

Adjuvant Chemoradiotherapy Yields 10-Year OS and RFS Advantages in High-Risk Endometrial Cancer - OncLive

Adjuvant Chemoradiotherapy Yields 10-Year OS and RFS Advantages in High-Risk Endometrial Cancer OncLive

Published: Oct. 15, 2025, 5:46 p.m.

Read Full Article

Rucaparib Maintenance Therapy Displays Activity in Pretreated Recurrent/Metastatic Endometrial Cancer - OncLive

Rucaparib Maintenance Therapy Displays Activity in Pretreated Recurrent/Metastatic Endometrial Cancer OncLive

Published: Oct. 15, 2025, 12:10 p.m.

Read Full Article

Endometrial Cancer Treatment Market Forecast to Reach USD 53.7 Billion by 2035, Driven by Innovation and Expanding Access to Care – FMIBlog - FMIBlog

Endometrial Cancer Treatment Market Forecast to Reach USD 53.7 Billion by 2035, Driven by Innovation and Expanding Access to Care – FMIBlog FMIBlog

Published: Oct. 15, 2025, 6:44 a.m.

Read Full Article

Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer - geneonline.com

Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer geneonline.com

Published: Oct. 14, 2025, 6:39 p.m.

Read Full Article

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - Bioengineer.org

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival Bioengineer.org

Published: Oct. 14, 2025, 4:49 p.m.

Read Full Article

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - BIOENGINEER.ORG

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival BIOENGINEER.ORG

Published: Oct. 14, 2025, 4:49 p.m.

Read Full Article

Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer - Nature

Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer Nature

Published: Oct. 14, 2025, 4:47 p.m.

Read Full Article

Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials - BMC Cancer

Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials BMC Cancer

Published: Oct. 14, 2025, 2:41 p.m.

Read Full Article

Jackie Burch dead: Breakfast Club and Die Hard legend dies after endometrial cancer battle - The Mirror

Jackie Burch dead: Breakfast Club and Die Hard legend dies after endometrial cancer battle The Mirror

Published: Oct. 14, 2025, 8:42 a.m.

Read Full Article

Latest Articles

Dr Pillay: Endometrial cancer on the rise - The Fiji Times

Adjuvant Chemoradiotherapy Yields 10-Year OS and RFS Advantages in High-Risk Endometrial Cancer - OncLive

Rucaparib Maintenance Therapy Displays Activity in Pretreated Recurrent/Metastatic Endometrial Cancer - OncLive

Endometrial Cancer Treatment Market Forecast to Reach USD 53.7 Billion by 2035, Driven by Innovation and Expanding Access to Care – FMIBlog - FMIBlog

Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer - geneonline.com

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - Bioengineer.org

Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - BIOENGINEER.ORG

Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer - Nature

Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials - BMC Cancer

Jackie Burch dead: Breakfast Club and Die Hard legend dies after endometrial cancer battle - The Mirror

Subscribe to Our Newsletter